Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study

Por Zhang, D S, Jin, Y, Luo, H Y, Wang, Z Q, Qiu, M Z, Wang, F H, Li, Y H, Xu, R H
Publicado no Br J Cancer (2015)

Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA Study

Por Jonas, Maureen M., Squires, Robert H., Rhee, Susan M., Lin, Chih‐Wei, Bessho, Kazuhiko, Feiterna‐Sperling, Cornelia, Hierro, Loreto, Kelly, Deirdre, Ling, Simon C., Strokova, Tatiana, del Valle‐Segarra, Antonio, Lovell, Sandra, Liu, Wei, Ng, Teresa I., Porcalla, Ariel, Gonzalez, Yuri Sanchez, Burroughs, Margaret, Sokal, Etienne
Publicado no Hepatology (2019)

Epratuzumab (humanised anti-CD22 antibody) in primary Sjögren's syndrome: an open-label phase I/II study

Por Steinfeld, Serge D, Tant, Laure, Burmester, Gerd R, Teoh, Nick KW, Wegener, William A, Goldenberg, David M, Pradier, Olivier
Publicado em 2006

Phase 2 study of CHOP-R-14 followed by (90)Y-ibritumomab tiuxetan in patients with previously untreated diffuse large B-cell lymphoma

Por Karmali, Reem, Larson, Melissa L., Shammo, Jamile M., Gregory, Stephanie A., O'Brien, Teresa, Venugopal, Parameswaran
Publicado no Mol Clin Oncol (2017)

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial

Por Carolyn S. P. Lam, Hillary Mulder, Yuri Lopatin, Jose B. Vazquez‐Tanus, David Siu, Justin Ezekowitz, Burkert Pieske, Christopher M. O’Connor, Lothar Roessig, Mahesh J. Patel, Kevin J. Anstrom, Adrian F. Hernandez, Paul W. Armstrong
Publicado em 2021-11-01

Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia

Por Ghobrial, Irene M., Gertz, Morie, LaPlant, Betsy, Camoriano, John, Hayman, Suzanne, Lacy, Martha, Chuma, Stacey, Harris, Brianna, Leduc, Renee, Rourke, Meghan, Ansell, Stephen M., DeAngelo, Daniel, Dispenzieri, Angela, Bergsagel, Leif, Reeder, Craig, Anderson, Kenneth C., Richardson, Paul G., Treon, Steven P., Witzig, Thomas E.
Publicado em 2010

Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European...

Por Raymond, Eric, Brandes, Alba A., Dittrich, Christian, Fumoleau, Pierre, Coudert, Bruno, Clement, Paul M.J., Frenay, Marc, Rampling, Roy, Stupp, Roger, Kros, Johan M., Heinrich, Michael C., Gorlia, Thierry, Lacombe, Denis, van den Bent, Martin J.
Publicado em 2008

Evaluation of two preoparative chemotherapy regimens for complete operability of advanced gastric adenocarcinoma: a clinical trial

Por S. Sedighi, M. Mohagheghi, F. Memari, R. Jahangir, A. Mousavi Jarrahi, A. Montazeri, Z. Sedighi, M. Mostaghimi Tehrani, M. Zanganeh
Publicado em 2006-08-01

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours

Por Ahn, H K, Choi, J Y, Kim, K-M, Kim, H, Choi, S-H, Park, S H, Park, J O, Lim, H Y, Kang, W K, Lee, J, Park, Y S
Publicado em 2013

Development and pilot testing of an intervention to promote care engagement and adherence among HIV-positive Kenyan MSM

Por Graham, Susan M., Micheni, Murugi, Kombo, Bernadette, Van Der Elst, Elisabeth M., Mugo, Peter M., Kivaya, Esther, Aunon, Frances, Kutner, Bryan, Sanders, Eduard J., Simoni, Jane M.
Publicado no AIDS (2015)

A phase I dose-escalation clinical trial of a peptide-based human papillomavirus therapeutic...

Por Greenfield, William W, Stratton, Shawna L, Myrick, Rebecca S, Vaughn, Rita, Donnalley, Lisa M, Coleman, Hannah N, Mercado, Maria, Moerman-Herzog, Andrea M, Spencer, Horace J, Andrews-Collins, Nancy R, Hitt, Wilbur C, Low, Gordon M, Manning, Nirvana A, McKelvey, Samantha S, Smith, Dora, Smith, Michael V, Phillips, Amy M, Quick, C Matthew, Jeffus, Susanne K, Hutchins, Laura F, Nakagawa, Mayumi
Publicado no Oncoimmunology (2015)

Sofosbuvir–velpatasvir single-tablet regimen administered for 12 weeks in a phase 3 study with minimal monitoring in India

Por Sood, Ajit, Duseja, Ajay, Kabrawala, Mayank, Amrose, Pradeep, Goswami, Bhadadev, Chowdhury, Abhijit, Sarin, Shiv Kumar, Koshy, Abraham, Hyland, Robert H., Lu, Sophia, Camus, Gregory, Stamm, Luisa M., Brainard, Diana M., Subramanian, G. Mani, Prasad, Madhura, Bhatia, Shobna, Shah, Samir R., Kapoor, Dharmesh, Shalimar, Saraswat, Vivek
Publicado no Hepatol Int (2019)

Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents

Por Saez-Llorens, Xavier, Aguilera Vaca, Diana Catalina, Abarca, Katia, Maho, Emmanuelle, Graña, Maria Gabriela, Heijnen, Esther, Smolenov, Igor, Dull, Peter M
Publicado no Hum Vaccin Immunother (2015)

Evaluation of who oral rehydration solution (ORS) and salt tablets in resuscitating adult patients with burns covering more than 15% of total body surface area (TBSA)

Por Moghazy, A.M., Adly, O.A., Elbadawy, M.A., Hashem, R.E.
Publicado no Ann Burns Fire Disasters (2016)

Phase 2 Study of Intralesional PV-10 in Refractory Metastatic Melanoma

Por Thompson, John F., Agarwala, Sanjiv S., Smithers, B. Mark, Ross, Merrick I., Scoggins, Charles R., Coventry, Brendon J., Neuhaus, Susan J., Minor, David R., Singer, Jamie M., Wachter, Eric A.
Publicado no Ann Surg Oncol (2014)

Phase IV study of retention on fingolimod versus injectable multiple sclerosis therapies: a randomized clinical trial

Por Cree, Bruce A.C., Arnold, Douglas L., Cascione, Mark, Fox, Edward J., Williams, Ian M., Meng, Xiangyi, Schofield, Lesley, Tenenbaum, Nadia
Publicado no Ther Adv Neurol Disord (2018)

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: a multicentre, open-label, phase 1 study

Por Laetsch, Theodore W., DuBois, Steven G., Mascarenhas, Leo, Turpin, Brian, Federman, Noah, Albert, Catherine M., Nagasubramanian, Ramamoorthy, Davis, Jessica L., Rudzinski, Erin, Feraco, Angela M., Tuch, Brian B., Ebata, Kevin T., Reynolds, Mark, Smith, Steven, Cruickshank, Scott, Cox, Michael C., Pappo, Alberto S., Hawkins, Douglas S.
Publicado no Lancet Oncol (2018)

Phase II Trial of Vorinostat With Idarubicin and Cytarabine for Patients With Newly Diagnosed Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Por Garcia-Manero, Guillermo, Tambaro, Francesco Paolo, Bekele, Nebiyou B., Yang, Hui, Ravandi, Farhad, Jabbour, Elias, Borthakur, Gautam, Kadia, Tapan M., Konopleva, Marina Y., Faderl, Stefan, Cortes, Jorge E., Brandt, Mark, Hu, Yumin, McCue, Deborah, Newsome, Willie Mae, Pierce, Sherry R., de Lima, Marcos, Kantarjian, Hagop M.
Publicado no J Clin Oncol (2012)

A Phase 1, open-label, multicentre study to compare the capsule and tablet formulations of AZD5363...

Por Dean, Emma, Banerji, Udai, Schellens, Jan H. M., Krebs, Matthew G., Jimenez, Begona, van Brummelen, Emilie, Bailey, Chris, Casson, Ed, Cripps, Diana, Cullberg, Marie, Evans, Stephen, Foxley, Andrew, Lindemann, Justin, Rugman, Paul, Taylor, Nigel, Turner, Guy, Yates, James, Lawrence, Peter
Publicado no Cancer Chemother Pharmacol (2018)

Adjuvant Hepatic Arterial Infusion Pump Chemotherapy After Resection of Colorectal Liver Metastases...

Por Buisman, Florian E., Grünhagen, Dirk J., Homs, Marjolein Y. V., Grootscholten, Cecile, Filipe, Wills F., Kemeny, Nancy E., Cercek, Andrea, D’Angelica, Micheal I., Donswijk, Maarten L., van Doorn, Leni, Emmering, Jasper, Jarnagin, William R., Kingham, T. Peter, Klompenhouwer, Elisabeth G., Kok, Niels F. M., Kuiper, Maria C., Moelker, Adriaan, Prevoo, Warner, Versleijen, Michelle W. J., Verhoef, Cornelis, Kuhlmann, Koert F. D., Groot Koerkamp, Bas
Publicado no Ann Surg Oncol (2019)